|
 |
EnbrelThis page contains recent news articles, when available, and an overview of Enbrel but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Enbrel (when available) Used in the treatment of rheumatoid arthritis and the reduction of the adverse effects of tumor necrosis factor (TNF). TNF is a naturally occurring cytokine that is involved in normal inflammatory and immune responses. Elevated levels of TNF are found in tissues and fluids of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (AS), and plaque psoriasis. Etanercept binds specifically to tumor necrosis factor (TNF) and blocks its interaction with cell surface TNF receptors. For treatment of severe adult and juvenille rheumatoid arthritis Mechanism Of Action: There are two distinct receptors for TNF (TNFRs), a 55 kilodalton protein (p55) and a 75 kilodalton protein (p75). The biological activity of TNF is dependent upon binding to either cell surface receptor (p75 or p55). Etanercept is a dimeric soluble form of the p75 TNF receptor that can bind to two TNF molecules, thereby effectively removing them from circulation. News Articles on Etanercept Turmeric (Curcumin) for Inflammatory Conditions - 05 Jan 2010 Inhibition of the production of TNF-alpha, which is the cytokine targeted by etanercept (Enbrel), infliximab (Remicade) and newer drugs; and 3. ... EmpowHer (blog) CORRECTED - UPDATE 1-Celgene psoriasis drug shows promise in trial - Dec 16, 2009 O) Enbrel, which dominates the psoriasis market. Enbrel, which inhibits a protein known as tumor necrosis factor, or TNF, is delivered by injection, ... Reuters Psoriasis can affect the joints as well as the skin - Dec 27, 2009 Two examples are etanercept (Enbrel) and infliximab (Remicade). Dear Dr. Donohue: All of a sudden, my left hip became painful. ... Herald & Review Roche and Biogen's Blockbuster Making Good Progress - Dec 11, 2009 For rheumatoid arthritis patients, Rituxan is only approved for patients who have failed an anti-TNF alpha treatment: Enbrel, Humira, and Remicade. ... Motley Fool Sjogren's Syndrome Update - Dec 31, 2009 Drugs under investigation include the TNF blocker etanercept (Enbrel). This is a powerful immune suppressive drug which have shown both great benefits and ... EmpowHer (blog) Breaking the generic biotech barrier - Jan 4, 2010 The 2012 patents include those on Enbrel and Remicade, both used to treat rheumatoid arthritis, as well as the lymphoma treatment Rituxan and the cancer ... JoongAng Daily TNF Blockers: Miracle Drugs or Minefields? - Dec 17, 2009 Etanercept (brand name Enbrel) is a protein produced by a different type of generically engineered cell culture. I think the name sounds similar to ... EmpowHer (blog) Biologics Transform RA Outlook - Dec 31, 2009 These were infliximab (Remicade), a monoclonal antibody against TNF, and etanercept (Enbrel), a soluble version of a TNF receptor protein, both of which sop ... MedPage Today Some Incyte Into Why These Drugs Rock - Dec 22, 2009 Johnson & Johnson's (NYSE: JNJ) and Merck's (NYSE: MRK) Remicade, and Pfizer's (NYSE: PFE) and Amgen's (Nasdaq: AMGN) Enbrel -- all have to be injected ... Motley Fool New Market Research Report from BioTrends Provides Insight on How ... - Dec 14, 2009 To be eligible for the audit, patients had to currently be treated with a biologic agent (UCB's Cimzia, Amgen/Wyeth's Enbrel, Abbott's Humira, Bristol Myers ... PR Newswire (press release) In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics ... - Dec 16, 2009 ..."Currently, biologic treatment for psoriasis is overwhelmingly dominated by Enbrel, Humira and Remicade as these agents have proved effective and, ... PR Newswire (press release) Medical marijuana attorney Rob Corry: "The future is here" - Dec 18, 2009 ...which also utilizes conventional pharmaceuticals, including Levothyroxin, Welbutrin, Nasacort, Protonix, Enbrel, Albutorol, Valium, Morphine Sulphate, ... Westword (blog) New and Upcoming Biologic Agents for Rheumatoid Arthritis - Dec 29, 2009 The first agents developed include TNF-æ±? blockers, infliximab (Remicade, Centocor), etanercept (Enbrel, Amgen), and adalimumab (Humira, Abbott) and the ... Ortho SuperSite Anti-smoking drugs in health basket - Dec 23, 2009 Avonex, Aricept, Exelon, Provigil and Targin for neurology; Byetta and Victoza for diabetes; Humira, Enbrel, Remicade and Amevive for dermatology; ... Jerusalem Post Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent ... - Dec 23, 2009 ...indicate that over 40% of their current patients on these newest TNF agents were switched from the current market share leaders Enbrel and Humira. ... PR Newswire (press release) Viron granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates - Dec 22, 2009 Viron's second therapeutic candidate, VT-346, is a powerful inhibitor of TNF-a, the therapeutic target of Enbrel(TM), Humira(TM), Cimzia(TM) and ... PR Newswire (press release) Biogen's RA Candidate Effective - Analyst Blog - Dec 14, 2009 Once launched, the product will compete with currently available treatments such as Pfizer/Amgen's (PFE/AMGN) Enbrel, Abbott's (ABT) Humira and Johnson ... Benzinga Report on global autoimmune disease therapeutics market - Dec 9, 2009 Biologics like Enbrel, Humira and Remicade have proved to be blockbuster drug due to their higher efficacy profiles. These drugs have recently gained ... News-Medical.net NICE wants more data on Roche arthritis drug - Dec 16, 2009 Sold elsewhere as Actemra, the drug competes with other existing meds such as Amgen's Enbrel (etanercept). NICE wants Roche to compare Actemra's cost and ... FiercePharma Nova droga contra psorÃase apresenta resultados promissores - Dec 16, 2009 Se for bem-sucedida, a droga competirá com o Enbrel, da Amgen Inc's, que domina o mercado de psorÃase. O Enbrel, que inibe uma proteÃna conhecida como fator ... O Globo 슈넬ìƒ?명과학, ê´€ì ˆì—¼ì¹˜ë£Œì œ ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ ìž„ìƒ?시험 계약 - Dec 15, 2009 64ì–µ9000만달러가 팔린 엔브ë ?(Enbrel)ì—? ì?´ì–´ 세계 2위 ë°”ì?´ì˜¤ì?˜ì•½í’ˆìœ¼ë¡œ 2014ë…„ 특허가 만료ë?œë‹¤. 슈넬ìƒ?명과학ì?€ ë‚´ë…„ ìƒ?반기 중 ì‹?약ì²ì—? ë ˆë¯¸ì¼€ì?´ë“œ ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ ... 매일경제 "Quan Ä?iểm Cao" và "Mua Thuốc Có Trong Formulary" - Dec 16, 2009 Chỉ những loại thuốc đắt tiá»?n và đặc trị thà dụ chữa bệnh viêm khá»›p do thấp (RA) nhÆ° Enbrel, Remicade vì đắt tiá»?n nên hoặc hãng bảo hiểm không trả hay bắt ... Người Việt ì…€ì , ê±´ì„ ì¹˜ë£Œ 실험약 중간 ìž„ìƒ? 성공ì ? - Dec 20, 2009 ...ì•„í”„ë ˆë°€ë¦¬ìŠ¤íŠ¸ê°€ ì‹œíŒ?ì—? ì„±ê³µí• ê²½ìš° ì•”ì ì?˜ '엔브ë ?(Enbrel)'ê³¼ ê²½ìŸ?í• ê²ƒìœ¼ë¡œ ì „ë§?ë??다. 엔브ë ?ì?€ ì£¼ì‚¬ì œì?¸ë?° 비해 ì•„í”„ë ˆë°€ë¦¬ìŠ¤íŠ¸ëŠ” ê²½êµ¬ì œì œë?¼ëŠ” 장ì ?ì?´ 있다. ... 데일리팜 Amgen: relève sa fourchette cible de BPA pour 2009. - Dec 18, 2009 ...et Neupogen ont augmenté de 2% à 1,21 milliard, alors que ceux du traitement contre la polyarthrite rhumatoïde Enbrel ont augmenté de 3% à 924 millions. Cercle Finance Stelara is Expected to Substantially Alter Patient Flow to TNF-Alpha ... - Nov 12, 2009 Humira will suffer the most as the agent garners use as a second-line biologic therapy following Enbrel and surveyed dermatologists indicate that more of ... PR Newswire (press release) Study Eases Arthritis Drug Cancer Fears - Oct 30, 2009 Oct. 29, 2009 - Rheumatoid arthritis patients who take the biologic drugs Remicade, Humira, and Enbrel do not appear to have an increased ... WebMD Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money - Nov 10, 2009 This approach could offer doctors an alternative to the $10 billion-a-year class of biotech drugs, like Amgen's etanercept (Enbrel) and Abbott Laboratories' ... Xconomy New drugs on the horizon - Nov 11, 2009 ENBREL, made by Imminex, and widely advertised in all sorts of magazines and on TV and specifically designed for treatment of rheumatoid arthritis. ... Liberty County Times Adeona Announces Publication of Results of 160 Patient Phase 2 Clinical Trial ... - Nov 13, 2009 DMARDs, including biologics such as Enbrel®, Humira®, Cimzia®, and Remicade®, accounted for nearly $5.0 billion of that figure. ... CNNMoney.com (press release) UK trust sues for Enbrel royalties - Oct 29, 2009 It has sued Amgen and Wyeth, seeking royalty payments for their arthritis drug Enbrel, Reuters reports. According to its court complaint, the trust holds a ... FiercePharma Study: No Benefit to Costly Arthritis Meds - Oct 23, 2009 The other two groups began with methotrexate alone, with step-up treatment adding either sulfasalazine/hydroxychloroquine or Enbrel only if they had ... CBS News Pfizer's new RA treatment shows promise - Nov 10, 2009 ...industry's most lucrative and fastest-growing therapy areas, currently dominated by drugs such as Wyeth's Enbrel and Johnson & Johnson/Merck's Remicade. ... Pharmafocus Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual ... - Oct 19, 2009 Enbrel is an inhibitor of TNF-alpha currently used for the treatment of rheumatoid arthritis. The presentation is being made at the 2009 Annual Scientific ... Reuters CEL-SCI Presents Data at American College of Rheumatology Conference Which ... - Oct 19, 2009 The long term results obtained with fewer doses of CEL-2000 vaccine were comparable or better than those seen with Enbrel®, a leading treatment for people ... Reuters TNF-Alpha Inhibitors Will Continue to Dominate First- and Second-Line Biologic ... - Oct 22, 2009 ..."Rheumatologists we surveyed prefer to prescribe Enbrel as a first-line biologic compared with either Humira or Remicade and they tell us that this pattern ... Reuters UPDATE 2-UK trust sues Amgen, Wyeth over Enbrel patent - Oct 28, 2009 Enbrel garners billions of dollars in annual sales for Amgen Inc (AMGN.O: Quote, Profile, Research) and Wyeth, which for years have co-marketed the drug. ... Reuters India Amgen Net Income Up 24 Percent - Oct 21, 2009 Worldwide Enbrel sales were up 3 percent to $924 million. Excluding one-time items, Amgen had adjusted earnings of $1.49 per share, helped by a tax benefit. ... Los Angeles Business Journal Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and ... - Nov 5, 2009 Mice treated with a combination of IMO-3100 and Enbrel had lower arthritic scores, less inflammation, and less bone pathology as compared to mice treated ... Reuters Medications for RA Linked to Skin Cancer - Oct 20, 2009 TNF blockers include Remicade, Enbrel, Humira, Cimzia, and Simponi. They neutralize a protein, tumor necrosis factor alpha, that is overproduced in ... WebMD TNF Blockers Do Not Increase Cancer Risk in Rheumatoid Arthritis Patients - Nov 2, 2009 University Hospital in Stockholm assessed short-term and medium-term cancer risk in rheumatoid arthritis patients using Remicade, Humira, and Enbrel. ... About - News & Issues (blog) Positive Rheumatoid Arthritis Data for UCB, Trubion, Others - Oct 19, 2009 The study looked at the medical and pharmacy claims of RA patients who filled their prescriptions for Humira or Enbrel at either specialty or retail ... OneMedPlace (blog) Study: No Benefit to Costly Arthritis Drugs - Oct 21, 2009 The other two groups began with methotrexate alone, with step-up treatment adding either sulfasalazine/hydroxychloroquine or Enbrel only if they had ... WebMD Cephalon Spies New Anti-TNF Use in BDC Takeover: Sciatica - Oct 26, 2009 The proof-of-concept test case is a candidate with a familiar name: etanercept, the subcutaneously injected blockbuster sold as Enbrel by Thousand Oaks, ... Therapeutics Daily (press release) (registration) How Drug Advertising Restrictions Could Benefit the Industry - Nov 5, 2009 Canada (where viewers are presumably unaffected by US drug advertising) showed no difference across the launch of three drugs, Nasonex, Enbrel and Zelnorm. BNET Pfizer cutting 600 jobs in area - Nov 9, 2009 Examples include the breast cancer drug Herceptin, arthritis drug Enbrel and cancer drug Avastin. Pfizer intends to maintain a presence in Chesterfield, ... St. Louis Post-Dispatch American College of Rheumatology (ACR) National Meeting, 2009: Update on Novel ... - Nov 4, 2009 Thus far, the studies show that JAK inhibitors have the potency of the biologic agents such as Humira and Enbrel, but they are obviously more attractive in ... Psychology Today (blog) InterMune Announces Appointments of Senior Leadership to Prepare for Potential ... - Nov 5, 2009 Mr. Cline led a managed care team during the launches of Aranesp® and Neulasta® and was the Reimbursement and Access Marketing Director for Enbrel®. ... Reuters Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical ... - Oct 27, 2009 In this position, he was responsible for the global portfolio of products that included Wyeth's biologic, Enbrel (R). During his 16 years at Wyeth, ... Reuters Band-Aid Won't Stop Generic Bleeding at Johnson & Johnson - Nov 11, 2009 However, as Remicade — like other immune-modulating TNF agents (Enbrel) — also inhibits tumorgenesis, the drug class has been implicated in recent cases of ... BNET Lawsuits, Drug Study Make for Bad Weeks for Amgen - Nov 8, 2009 ...blockbuster anemia drug, Aranesp, continue to decline, and the company is experiencing increased competition for its rheumatoid arthritis drug, Enbrel. ... San Fernando Valley Business Journal Is Amgen retreat a case of investor overreaction? - Nov 5, 2009 Moreover, sales growth for Enbrel, Amgen's popular rheumatoid-arthritis drug, has been slowing with the entrance of several rival medications into the ... Middle East North Africa Financial Network Biosimilars of TNF-alpha Inhibitors Stand to Erode Over $9 Billion in Brand ... - Nov 3, 2009 ...forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira ... Reuters Decision Resources: Biosimilars may cause biotech companies to lose more than ... - Nov 11, 2009 TNF-alpha inhibitors include Enbrel (etanercept), by Amgen and Eli Lilly & Co., Abbott's Humira (adalimumab) and Remicade (infliximab), ... Drug Store News (blog) Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roche's ... - Nov 2, 2009 ...trials for TNF-alpha inhibitors such as Amgen/Pfizer's Enbrel and Abbott's Humira, the two leading agents in the rheumatoid arthritis drug market. ... Reuters Marketing Drugs: The Pitfalls of DTC - Nov 5, 2009 Enbrel is an Amgen brand that has benefitted very much from DTC marketing thank you. These articles are sure to cause DTC marketers more headaches as ... BusinessWeek Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to ... - Oct 21, 2009 Sales of Enbrel(®) (etanercept) increased 3 percent in the third quarter of 2009 to $924 million versus $893 million in the third quarter of 2008, ... Reuters xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts October 19, 2009 ... - Oct 19, 2009 Enbrel is an inhibitor of TNF-alpha currently used for the treatment of rheumatoid arthritis. The presentation is being made at the 2009 Annual Scientific ... Trading Markets (press release) The revolution in battling child arthritis - Oct 21, 2009 ...required its strongest "black box" warnings on the entire class, which includes drugs sold under the names Humira, Cimzia, Enbrel, and Remicade. ... Philadelphia Inquirer CEL-SCI's LEAPSâ„¢ Inventor Excited By Treatment's Progress - Oct 20, 2009 10/20/2009 (BAYSTREET NEWSWIRE) In the mid 80's, Dr. Daniel Zimmerman, inventor of the LEAPSâ„¢ technology, and a long-time member of the team at CEL-SCI ... Baystreet.ca Option Trading Explodes on MGM Mirage (MGM) - Oct 19, 2009 Also, it will cease sharing profits with Wyeth (WYE) on it's rheumatoid arthritis drug enbrel. Amgen IV should also drop after the possible 10/19 PDUFA date ... Schaeffers Research Access to US biosimilars market set to get tougher - Nov 9, 2009 Patents on Amgen's Enbrel (used for treatment of arthritis and psoriasis, $5.7 bn sales in 2008), Neupogen (for neutropenia, which is a side effect of ... Daily News & Analysis High Court rejects B-MS bid for NICE legal challenge - Nov 10, 2009 At the time, the Institute argued that it had already given the OK to Abbott Laboratories' Humira (adalimumab), Wyeth's Enbrel (etanercept) and ... Pharma Times Genzyme Could Get 'ERT' as Pharma Makes Gaucher Bids - Nov 4, 2009 The company already has started work on a version of antitumor necrosis factor-alpha drug Enbrel (etanercept, Amgen Inc.), which it hopes to market at a ... BioWorld Online Study Links Rheumatoid Arthritis Drug Adherence to Improved Medical Outcomes ... - Oct 19, 2009 ...use of medical services, and treatment costs when patients using either adalimumab (Humira®) or etanercept (Enbrel®) obtained these medications through ... Reuters China Biotech Week in Review: Is CRO Consolidation a New Theme? - Nov 1, 2009 Etanercept is a TNF inhibitor marketed as Enbrel by Amgen (NSDQ: AMGN) and Wyeth (NYSE: WYE) and in Japan by Takeda Pharma. Sinovac Biotech (SVA) received a ... Seeking Alpha (blog) Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive ... - Oct 26, 2009 The new Pharmacor report entitled Psoriasis finds that, among the TNF-alpha inhibitors, Amgen/Pfizer/Takeda's Enbrel maintained its market dominance in 2008 ... Reuters More Tysabri Problems; Time for a Biogen-Idec Credibility Check - Oct 30, 2009 ...such as the well-known tumor necrosis factor (TNF)-alpha antagonist Enbrel (Etanercept), the anti-CD52 antibody Campath (alemtuzumab), ... BNET ACR: No Special Benefit Seen with Biologic RA Drugs - Oct 20, 2009 ...sulfasalazine and hydroxychloroquine (the traditional combination), or methotrexate plus the antitumor necrosis factor (TNF) drug, etanercept (Enbrel). ... MedPage Today Deals of the Week: Trick or Treat! - Oct 30, 2009 The acquisition depends entirely on the outcome of BioAssets' ongoing Phase II trial of etanercept (Enbrel) for sciatic pain, due next year. ... The IN VIVO Blog (blog) Biosimilar TuNEX® from Mycenax completes Phase I/II clinical trial in Taiwan ... - Oct 23, 2009 Dr. Michael Hwang, Mycenax founder and president said, "With TuNEX® being an INN etanercept biosimilar to Enbrel®, the world's largest biological ... eTaiwan News ACR: Markers Identify RA Patients Who Need Early Med Switch - Oct 19, 2009 The study used data from a randomized trial called TEMPO that compared methotrexate plus placebo to a combination of methotrexate and etanercept (Enbrel). ... MedPage Today Can curry spice soothe psoriasis? - Oct 28, 2009 Powerful immune-system modulating drugs like Enbrel and Remicade used to treat rheumatoid arthritis can set off a new attack of psoriasis. ... Pasadena Star-News Revolutionary New Treatment for Sciatica Advances in the Clinic - Oct 27, 2009 For example, Amgen and Wyeth, the US manufacturers of etanercept, have been sued for alleged off-label promotion of Enbrel®, their brand of etanercept(US ... PR Web (press release) Pfizer 3Q profit jumps 26 percent on cost cutting - Oct 20, 2009 ...treatment Norvasc, plus Wyeth's antidepressant Effexor, children's pneumococcal vaccine Prevnar and Enbrel, a biotech drug for rheumatoid arthritis. ... The Associated Press FDA Panel Recommends Enbrel for Pediatric Patients - Jun 18, 2008 By Amanda Gardner. WEDNESDAY, June 18 (HealthDay News) -- A US Food and Drug Administration advisory panel recommended Wednesday that the psoriasis drug ... Washington Post J&J psoriasis drug beats top-seller Enbrel in trial - Sep 19, 2008 By Ransdell Pierson. NEW YORK (Reuters) - Johnson & Johnson (JNJ.N) said on Thursday its experimental psoriasis drug proved more effective than top-selling ... Reuters Amgen pulls Enbrel TV ad on FDA order - Feb 19, 2005 By Carla Mozee, MarketWatch. SAN FRANCISCO (MarketWatch) - Amgen Inc. was ordered by regulators to pull a television ad that overstated the effectiveness of ... MarketWatch Court rules for Amgen in Enbrel-related patent suit - Jan 29, 2007 By Paula L. Stepankowsky. Amgen Inc. (AMGN) prevailed in a long-running patent dispute over its rheumatoid arthritis drug Enbrel Monday when a US federal ... MarketWatch Amgen salespeople allege improper Enbrel promotion - Jan 10, 2008 LOS ANGELES (Reuters) - Two former salespeople for Amgen Inc (AMGN.O) are suing the company for lost wages and other compensation after refusing to ... Reuters Remissions up with Amgen's Enbrel plus methotrexate - Nov 7, 2007 LOS ANGELES, Nov 7 (Reuters) - Early results from an ongoing study showed that people with newly diagnosed rheumatoid arthritis were more likely to reach ... Reuters Amgen Has Positive Enbrel Data - Nov 13, 2006 Amgen(AMGN Quote) said people with the inflammatory disease ankylosing spondylitis showed a sustained improvement in their symptoms over three years while ... TheStreet.com - TheStreet.com (subscription) NJ subpoenas Amgen records on marketing Enbrel - Jan 17, 2008 By JEFFREY GOLD, AP Business Writer. New Jersey investigators on Thursday said they have subpoenaed records from Amgen Inc. following accusations from two ... San Francisco Chronicle In Brief / HEALTHCARE; Amgen warns of Enbrel risk - Mar 18, 2008 Amgen Inc. and Wyeth added the strongest Food and Drug Administration warning to the prescribing information for the arthritis drug Enbrel to highlight the ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Wyeth Has 4th-Qtr Profit; Prevnar, Enbrel Sales Rise - Jan 31, 2006 By Nicole Ostrow. Jan. 31 (Bloomberg) -- Wyeth posted a fourth-quarter profit as higher sales of the Prevnar meningitis vaccine and Enbrel arthritis ... Bloomberg Amgen yanks ad for Enbrel - Feb 22, 2005 The 60-second TV spot advertised Enbrel as a treatment for psoriasis -- a recurring skin disease that causes red, inflamed patches on the skin. ... Pay-Per-View - Providence Journal - ProQuest Archiver US FDA: Amgen, Wyeth's Enbrel drug to carry warning - May 2, 2008 WASHINGTON, May 1 (Reuters) - The US Food and Drug Administration said on Thursday that Amgen Inc (AMGN.O: Quote, Profile, Research) and Wyeth's WYE. ... Reuters India Vertex pill could eclipse Enbrel: CEO - Feb 21, 2006 By Ransdell Pierson and Lewis Krauskopf. BOSTON (Reuters) - The chief executive officer of Vertex Pharmaceuticals Inc. (VRTX.O: Quote, Profile, Research, ... Reuters Long-Term Psoriasis Relief With Enbrel - Jun 18, 2007 By none. "The bottom line is that all of this is an understatement. In real life we. rarely tell patients, 'Just use this Enbrel and that is it. ... CBS News Amgen CEO says hot drug Enbrel means more jobs ahead for Rhode … - Oct 17, 2005 Oct. 17--PROVIDENCE -- Kevin Sharer, head of the world's largest biotechnology company, is clear about what he wants. Sharer wants Amgen Inc. to sell $3 ... Free with registration - Providence Journal - AccessMyLibrary.com Amgen's Enbrel in kids 'concerning'-FDA staff - Jun 16, 2008 By Susan Heavey. WASHINGTON, June 16 (Reuters) - US Food and Drug Administration reviewers are concerned about life-threatening complications in children ... Reuters India California and the West; Amgen's Earnings Rise 14% to $1 Billion - Apr 19, 2006 ..."With the exception of Enbrel, product performance was in line with expectation," ... Morrow said that Enbrel slipped from a 43% to a 41% share of the ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Psoriasis Drug May Also Clear Up Depression and Fatigue - Dec 15, 2005 15 - At the same time that Enbrel (etanercept), a tumor necrosis ... Enbrel is approved by the FDA for treating symptoms of psoriasis as well as psoriatic ... CNN Drug nets $284m for MGH. - Apr 19, 2007 General relinquished rights to royalties on Enbrel sales in the United States. ... Enbrel researchers used that technique for arthritis, blocking the body's ... Free with registration - Boston Globe - AccessMyLibrary.com Amgen 1st-Quarter Net Rises 2% on Enbrel Sales Growth - Apr 24, 2008 By Luke Timmerman. April 24 (Bloomberg) --Amgen Inc., the world's largest biotechnology company, said first-quarter profit climbed 2 percent as demand for ... Bloomberg Amgen to pay Mass. General $186m - Jun 6, 2006 Combined Enbrel royalties accounted for almost 75 percent of the nearly $90 million ... Originally intended to treat rheumatoid arthritis, Enbrel later won ... Boston Globe Amgen yanks ad for Enbrel. | Article from Providence Journal (Providen... - Feb 22, 2005 Amgen yanks ad for Enbrel. ... find Providence Journal (Providence, RI) articles. Byline: Andrea L. Stape Feb. 22--The US Food and Drug Administration has ... Pay-Per-View - Providence Journal - HighBeam Research Business | projo.com | The Providence Journal - Mar 21, 2007 The increased revenue from Enbrel resulted from growing demand for the ... In 2005, Enbrel sales increased 35 percent, and total product sales jumped 20 ... Providence Journal Enbrel Works for Kids With Psoriasis - Jan 16, 2008 By Salynn Boyles. Jan. 16, 2008 -- The itchy, red, and silvery skin patches that are the hallmark of psoriasis were constant companions for Maria Anichini ... WebMD Drug firm, MGH fight over royalties.(Massachusetts General Hospital ) - Jun 28, 2005 Amgen Inc. last year sold nearly $2 billion worth of Enbrel, which doctors ... She declined to say how much of its Enbrel royalties might be in jeopardy. ... Free with registration - Boston Globe - AccessMyLibrary.com FDA reviews Enbrel, Humira and Remicade - Jun 4, 2008 WASHINGTON, June 4 (UPI) -- The US Food and Drug Administration has announced a safety review of several drugs known as tumor necrosis factor, or TNF, ... United Press International Wyeth Raises Forecast as Profit Jumps - Jul 20, 2007 ...“Strong growth for Enbrel and Prevnar internationally should fuel earnings growth for the next few years,â€? said Barbara Ryan of Deutsche Bank in New York. ... New York Times Big Drugs Bolster Wyeth | Pharmaceuticals | Financial Articles &... - Oct 19, 2006 The third-quarter results were enhanced by healthy returns from Enbrel and Prevnar. Wyeth has the rights to Enbrel outside the US and Canada. ... TheStreet.com - TheStreet.com (subscription) Amgen gets OK to make Enbrel. - Sep 2, 2005 Sep. 2--The US Food and Drug Administration yesterday signed off on Amgen Inc.'s second drug manufacturing facility in West Greenwich, allowing the company ... Free with registration - Providence Journal - AccessMyLibrary.com Study: Enbrel Plus Methotrexate May Increase Rheumatoid Arthritis … - Jul 15, 2008 By Miranda Hitti. July 15, 2008 -- In the early stages of rheumatoid arthritis, taking the drugs Enbrel and methotrexate may make remission more likely than ... WebMD Amgen lifts profit forecast, shares higher - MarketWatch - Jul 20, 2005 Amgen saw particularly robust growth in sales of its anemia drug Aranesp and Enbrel, a treatment for rheumatoid arthritis and psoriasis. ... MarketWatch Enbrel Provides Sustained Clinical Improvements for People With … - Nov 20, 2006 THOUSAND OAKS, CA -- November 20, 2006 -- Amgen, announced that data from an ongoing open-label, multinational, phase 4 extension study showed that patients ... DG News Important Information for Patients About enbrel (etanercept) . - Dec 16, 2007 This brief summary of the package insert contains information for patients and their caregivers about ENBREL This bnet summary does not include all ... Lakeland Ledger - Google News Archive Humira, Cimzia, Enbrel and Remicade to Bear Stronger Infection … - Sep 4, 2008 Federal regulators have ordered the makers of Humira, Cimzia, Enbrel, and Remicade to strengthen the existing warnings about opportunistic fungal infections ... Newsinferno.com … ENBREL Psoriatic Arthritis Indication -- ENBREL Approved As First... - Jun 1, 2005 Amgen Inc. (NASDAQ:AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), today announced that the US Food and Drug Administration (FDA) approved ... RedOrbit Caution urged in Alzheimer's study; Much more research is needed, … - Jun 26, 2006 Enbrel is linked to infections and symptoms of multiple sclerosis. ... He offers Enbrel to selected Alzheimer's patients outside of clinical studies. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver FDA Panel OKs Enbrel For Kids' Psoriasis - Jun 20, 2008 An FDA advisory committee has voted to recommend the biologic drug Enbrel's approval to treat plaque psoriasis in some children and teens. (CBS/AP) ... CBS News Wyeth 2nd-quarter profit rises on strength in Enbrel and Prevnar - Jul 19, 2007 AP. TRENTON, NJ - Wyeth said Thursday its second-quarter profit rose about 13 percent as the drug maker posted strong sales of inflammatory disease drug ... phillyBurbs.com Amgen CEO says hot drug Enbrel means more jobs ahead for Rhode … - Oct 17, 2005 Amgen CEO says hot drug Enbrel means more jobs ahead for Rhode Island. ... find Providence Journal (Providence, RI) articles. Byline: Andrea L. Stape Oct. Pay-Per-View - Providence Journal - HighBeam Research Cancer risk from arthritis drugs overstated-study - Nov 7, 2006 His team is looking at a third drug in the same class, Amgen's Enbrel, known generically ... So far, studies have shown no link between Enbrel and cancer or ... Reuters Celgene drug hits goal in psoriasis trial - May 22, 2007 O) Enbrel, Johnson & Johnson's (JNJ.N) Remicade and Abbott Laboratories Inc.'s (ABT.N) Humira. Piper Jaffray analyst Rachel McMinn said in a research note ... Reuters Wyeth Rises as Profit Tops Estimates on Enbrel Sales - Jul 23, 2008 By Tom Randall. July 23 (Bloomberg) -- Wyeth, maker of the world's best- selling antidepressant, gained in New York trading after sales of a pneumonia ... Bloomberg Analysts disappointed about Amgen sales, despite increase - Apr. 18, ... - Apr 18, 2006 Neulasta and Neupogen are used to fight infections in chemotherapy patients, and Enbrel is a treatment for various types of arthritis. ... CNNMoney.com Wyeth Warns of Drug Delays - Apr 19, 2007 Sales of Enbrel, for diseases such as rheumatoid arthritis and psoriasis, ... Wyeth sells Enbrel outside the US and Canada. Amgen(AMGN Quote) covers the ... TheStreet.com - TheStreet.com (subscription) Pfizer's earnings increase 21% - Jul 21, 2005 Wyeth is counting on products such as Prevnar and Enbrel to help expand future earnings as competition increases for its biggest product, the antidepressant ... New York Times FDA Reviews Arthritis Drugs for Links to Cancer - Jun 5, 2008 The drugs involved are Enbrel, sold by Amgen and Wyeth; Remicade, ... Remicade, Humira and Enbrel had combined sales of more than $13 billion last year. ... New York Times Wyeth Beats Profit Targets - Apr 21, 2006 Wyeth sells Enbrel outside the US and Canada. Amgen (AMGN:Nasdaq) markets the drug in those two markets, where first-quarter sales rose 11% to $658 million. ... TheStreet.com - TheStreet.com (subscription) Biotech Knockoffs - Mar 15, 2007 Amgen's Enbrel markedly improves psoriasis in three-quarters of patients who ... For Enbrel it's $15000 per year. Generics would seem the quickest way to ... Forbes FDA Expands ENBREL Psoriatic Arthritis Indication - Jun 3, 2005 Amgen Inc and Wyeth Pharmaceuticals, a division of Wyeth, today announced that the US Food and Drug Administration (FDA) approved an expanded indication for ... i-newswire.com Study Showed Half Of Patients Treated With Enbrel(R) (etanercept)... - Jul 20, 2008 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Amgen (NASDAQ:AMGN) announced the publication of data from the COMET (COmbination of Methotrexate ... Medical News Today - Medical News Today (press release) Wyeth Forecasts Earnings Growth of 10% - Jan 10, 2006 Wyeth said it expects international revenue growth for the arthritis drug Enbrel to be in excess of 30 percent in 2006. Wyeth has exclusive sales rights to ... FOXNews Amgen cuts work-force reduction plan to 300 - Oct 25, 2007 That plan changed following an internal analysis of the demand for the drug Enbrel, produced for the North American market at two plants in Rhode Island. ... Providence Journal Ex-Reps Say Amgen Used Patient Records - Jan 9, 2008 Enbrel, an injected, genetically engineered drug, is only approved for use ... Enbrel, one of Amgen's top sellers, had sales of nearly $3 billion in 2006. ... San Francisco Chronicle Alzheimer's: A new indication for Enbrel? - Jan 10, 2008 For yet another example of the trend toward teaching old drugs new tricks, check out Exhibit E for Enbrel. According to research released today, ... FiercePharma Enbrel is a costly, effective medicine - Jan 6, 2008 Question: Could you discuss the use of Enbrel for rheumatoid arthritis? My doctor thinks I may be a candidate for this medication, but I hear it is very ... Pay-Per-View - Orlando Sentinel - ProQuest Archiver Adult drug for psoriasis shown to be effective in children - Jan 21, 2008 Paller and her colleagues knew that some adults treated with Enbrel improved dramatically ... Half received an injection of Enbrel once a week for 12 weeks; ... USA Today Senate looking into Amgen's ethics in marketing Enbrel - Feb 11, 2008 By LINDA A. JOHNSON. AP. TRENTON, NJ -- First one former sales representative, then another from drug maker Amgen Inc. claimed they were fired or forced out ... Seattle Post-Intelligencer - Seattle Post Intelligencer Wyeth signs three biotech product deals: The agreements were an … - Jan 9, 2006 Enbrel, which Wyeth comarkets with Amgen, had $2.6 billion in global sales for the ... In addition to Enbrel and Prevnar, they include two hemophilia drugs, ... Free with registration - Philadelphia Inquirer - AccessMyLibrary.com New Drugs Offer More Choices for Psoriasis - Dec 20, 2005 Remicade, Enbrel and Humira aim at a different player, a protein called TNF-alpha, for tumor necrosis factor-alpha, that is an important immune activator in ... New York Times Pomp and Promise in Biotechland - Jan 9, 2007 Along with psoriasis, Enbrel also treats various forms of arthritis. Myriad Genetics (MYGN - commentary - Cramer's Take) barely mentioned halting the ... TheStreet.com - TheStreet.com (subscription) Pharma Oversold? - Sep 1, 2008 Researchers looked at three drugs over a five-year period: Enbrel, for arthritis, ... For two drugs, Enbrel and Nasonex, the $194 million and $235 million ... Forbes Wyeth 3Q profit falls but meets forecasts - Oct 22, 2008 Looking ahead, Poussot said both Prevnar and Enbrel are poised to help buoy the company's revenue in the coming years. For example, the company is looking ... FOXNews The recalled diet drug's maker surprised markets with a loss of $1.76... - Feb 1, 2005 Sales for Wyeth's arthritis drug Enbrel rose 46 percent to $1.9 billion in North America, where it is marketed by Amgen Inc. Outside North America, ... $2.95 - Philadelphia Inquirer - NewsBank Drug switch may benefit arthritis patients - Aug 31, 2007 The most common initial drug was infliximab (Remicade), and second-line agents were usually adalimumab (Humira) or etanercept (Enbrel). ... Reuters UK Amgen earnings, sales beat forecast - Jan 24, 2008 Sales for Enbrel, a treatment for inflammatory diseases including psoriasis ... Amgen sells Enbrel in the US, and its partner Wyeth (WYE, Fortune 500) sells ... CNNMoney.com Alzheimer's patients may also experience benefits - Jul 21, 2008 Etanercept (Enbrel), an antiTNF drug developed to treat rheumatoid arthritis, transformed the behaviour of some patients in a matter of minutes, ... Times Online Wyeth 1Q profit falls but tops expectations; backs outlook - Apr 22, 2008 ...following the launch of a generic version late last year by Teva Pharmaceutical Industries Ltd., but sales of arthritis drug Enbrel spiked 36 percent. ... USA Today Wyeth posts flat profit, but raises forecast - Oct 22, 2008 N to Enbrel in the United States and Canada. Wyeth's share of sales in those markets rose 23 percent to $294 million. Sales in other markets, ... Reuters New Data Reinforce Safety Profile of Etanercept - Oct 6, 2006 Enbrel is a biologic, meaning a biotechnologically produced medicine, ... The OL study confirmed that the overall safety profile of Enbrel did not change ... DG News Amgen 2Q profit falls on restructuring, charges - Jul 29, 2008 ...which prevent infections in chemotherapy patients, rose 15 percent to $1.20 billion, while sales of the rheumatoid arthritis drug Enbrel rose 2 percent ... Los Angeles Times UI sues over violations of 2 patents - Sep 9, 2008 ...abide by the patents and stop using the inventions to manufacture drugs "such as its multibillion-dollar blockbuster drug Enbrel," the complaint states. ... $3.50 - The Gazette - NewsBank Amgen will lay off 450in West Greenwich | Rhode Island news |... - Sep 25, 2007 Sales of Enbrel, the drug Amgen produces in Rhode Island, have continued to grow during this period, ... Enbrel is used for treating rheumatoid arthritis. ... Providence Journal CORRECTED - (OFFICIAL)-J&J exec says psoriasis drug could dominate - May 15, 2008 Elliott said it would compete directly with Enbrel, a blockbuster medicine sold jointly by Wyeth WYE.N and Amgen (AMGN.O: Quote, Profile, Research) that now ... Reuters India Paula Abdul Says Quirky Behavior Isn't From A Drug Problem - Apr 21, 2005 Now, thanks to the anti-inflammatory drug Enbrel, Abdul said she's finally living a pain-free life. However, the singer has faced her share of ups and downs ... MTV.com … Demonstrated Superior Efficacy To Enbrel(R) (Etanercept) In Treatme - Sep 19, 2008 New findings from a Phase 3 multicenter, randomized head-to-head study comparing ustekinumab and Enbrel(R) (etanercept) for the treatment of moderate to ... Medical News Today - Medical News Today (press release) Business briefs -- 07/27 | Business | PE.com | Southern California... - Jul 26, 2007 Amgen Inc., the world's largest biotechnology company, said second-quarter revenue rose 3.4 percent, as sales of the rheumatoid arthritis drug Enbrel offset ... Press-Enterprise No Easy Cure for Amgen's Ailment - Jan 28, 2005 In fact, Amgen's biggest hit drugs -- Enbrel for rheumatoid arthritis and psoriasis, Neulasta for preventing infections in patients on chemotherapy, ... BusinessWeek What's behind the whopping price tags on the newest generation of... - Aug 18, 2008 The story behind the production of Enbrel, Amgen's popular rheumatoid- arthritis drug, ... Amgen tried to find a cheaper way to make Enbrel, its blockbuster ... Seattle Times Merck, Wyeth Shares Fall After Reports - Jan 30, 2007 Sales of biotechnology drugs, which include Prevnar and Enbrel, rose 23 percent for the year, and now account for almost 35 percent of pharmaceutical ... FOXNews New Data Reinforce Safety Profile Of ENBREL(REG) (Etanercept) - Oct 7, 2006 There was good news for psoriasis patients this week, as the latest study confirming the established safety profile of ENBREL® (etanercept) for up to 2.5 ... Medical News Today - Medical News Today (press release) Wyeth third-quarter profits fall 39 percent. - Oct 22, 2005 Wyeth markets Enbrel with partner Amgen Inc. Wyeth sells Enbrel outside of North America, where sales were $276 million in the quarter, an increase of 59 ... Free with registration - Philadelphia Inquirer - AccessMyLibrary.com Wyeth 3Q profit falls on charge - Oct 18, 2007 Enbrel has become the No. 6 drug in worldwide sales, as it goes on the market ... Brozak said the growth in sales of Enbrel and Wyeth's vaccines were bright ... San Diego Union - Tribune - San Diego Union Tribune Arthritis treatment could cut psoriasis - Jan 17, 2008 In more than half of patients, a three-month course of weekly injections of etanercept, sold under the name Enbrel in Britain, cleared at least three ... Telegraph.co.uk Important Information For Patients About Enbrel (etanercept) . - Dec 16, 2007 ...caregivers about ENBREL This brief summary does not include all information about ... What is the most important information I should know about ENBREL? ... Toledo Blade - Google News Archive NHS to review arthritis drugs use - Jun 12, 2007 The National Institute for Health and Clinical Excellence (NICE) will look again at Humira, Enbrel and Remicade. Last year it ruled if a patient did not ... BBC News Abdul says odd behavior not drug-related - Apr 20, 2005 The turning point came last summer, she says, when she began taking Enbrel, an anti-inflammatory drug normally used to treat rheumatoid arthritis and ... USA Today Amgen profits surge on reduced expenses - Oct 24, 2008 ...biotech treatments, including Neulasta, which prevents infections in chemotherapy patients, and Enbrel, which is used to treat rheumatoid arthritis. ... USA Today Setback for arthritis sufferers as officials stall decision on drug... - Oct 24, 2007 In guidance published today on the anti-TNF drugs Remicade, Enbrel and Humira, ... Enbrel and Humira are given by regular self-administered injections. ... Daily Mail Wyeth 3Q profit falls 39 percent on charges; stock dips - Oct 21, 2005 Those include Enbrel and Prevnar, as well as hemophilia medicines BeneFIX and ... North American sales of Enbrel, which Wyeth markets with partner Amgen, ... $2.95 - Associated Press Archive - NewsBank ENBREL Safety Data for up to Eight Years in Patients with Juvenile … - Jun 13, 2007 THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa. -- Amgen (NASDAQ:AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), today announced the presentation ... $4.95 - Business Wire - ECNext Profit jump not enough for Amgen watchers - Oct 20, 2005 Sales of Enbrel for arthritis and the skin condition psoriasis jumped 35 ... Enbrel was developed by Seattle-based Immunex, which Amgen bought in 2002. ... Seattle Times Wyeth Earnings Dip Slightly - Oct 22, 2008 Revenue in the quarter rose to 4% to $5.8 billion, driven by increases in Enbrel, Prevnar and its nutritionals franchise, the company said Wednesday. ... TheStreet.com - TheStreet.com (subscription) Business Briefing / PHARMACEUTICALS; Amgen wins patent ruling - Sep 23, 2008 Biotechnology giant Amgen Inc. won a court ruling that its Enbrel arthritis drug ... "The evidence of record establishes that Enbrel acts outside of cells, ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Amgen's acquisition charges cuts profit; stock rises on outlook. - Jul 20, 2006 Enbrel, a rheumatoid-arthritis treatment that Amgen sells in the US and Canada ... Marketing partner Wyeth , which sells Enbrel overseas, earlier reported a ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Treatment With ENBREL Had a Positive Effect on Activities of Daily... - Feb 18, 2005 At three months, nearly 30 percent of 311 patients with moderate-to-severe psoriasis who were taking Enbrel(R) (etanercept) reported that they were "not at ... RedOrbit Amgen's Enbrel improves psoriasis patients' wellbeing - Feb 21, 2005 Amgen has revealed that treatment with its rheumatoid arthritis drug, Enbrel, had a positive effect on the activities of daily living for patients with ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones UK's NICE paves way for wider arthritis drugs use - Jun 11, 2007 The drugs affected are Enbrel, which is sold in Europe by Wyeth (WYE.N), Remicade, marketed by Schering-Plough Corp. (SGP.N), and Abbott Laboratories Inc.'s ... Reuters Amgen Is a Penny Light | Biotech/Pharmaceuticals | Financial Articles... - Jan 26, 2006 Sales of Neulasta and Neupogen rose 19% to $928 million, while sales of Enbrel rose 19% to $674 million. "2005 was another strong year for Amgen," the ... TheStreet.com - TheStreet.com (subscription) Enbrel SubQ : Uses, Side Effects, Interactions, Pictures, Warnings & ... - May 3, 2007 This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD Enbrel shown to significantly reduced levels of C-reactive protein - Feb 5, 2008 Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced ... News-Medical.net Brand Names/Synonyms: Enbrel is also known by the following brand names and/or synonymsTumor necrosis factor receptor superfamily member 1B precursor;Tumor necrosis factor receptor 2;TNF-R2;Tumor necrosis factor receptor type II;p75;p80 TNF-alpha receptor;CD120b;Etanercept[Contains: Tumor necrosis factor binding protein 2;TBPII;TBP-2]; Enbrel (Immunex Corp) Drug Category: Enbrel is categorized under the following by the FDA: Immunomodulatory Agents; Antirheumatic Agents; unclassified therapeutic agents (92:00.00) Dosage Forms: KIT;LIQUID;POWDER FOR SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Human tumor necrosis factor receptor fusion protein |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
